Anne Chauveau

Anne Chauveau is a Group Leader at Adaptimmune, specializing in Translational Science and the Mechanistic Team since April 2022. Previously, Anne served as a Principal Scientist focused on Discovery Research and Immunology in Next Generation Cell Therapy. Prior to Adaptimmune, academic contributions were made as a Postdoctoral Researcher at the University of Oxford from June 2014 to March 2022 and as a Postdoctoral Research Fellow at Memorial Sloan-Kettering Cancer Center from September 2010 to June 2014. Anne holds multiple degrees in Immunology and Cell Biology, including PhDs from Imperial College London and Aix-Marseille University, as well as Master's degrees and a Bachelor's degree in relevant fields from prestigious institutions.